Test Performance. Life Technologies shall have the responsibility, subject to its capacity to support in its reasonable discretion (of which capacity Life Technologies shall notify Biocept in writing at least sixty (60) days before launch of the Assay, and use diligent efforts to notify Biocept at least thirty (30) days before discovery of any decreases or increases in such capacity), for performing the Professional Component of the Assays sold by either party in the Territory. In particular, the laboratory director of the Life Technologies CLIA laboratory will be responsible for issuing and signing off on the report.
Test Performance. Test performance will be subject to the following rules:
Test Performance. Clarient shall have responsibility for performing, or having performed on its behalf, all Professional Components of the Diagnostic Tests sold by either party, or by any Third Party in accordance with Section 2.3(a).
Test Performance. Biocept shall be responsible for performing all Technical Components of all Diagnostic Tests sold by either party, or by any Third Party in accordance with Section 2.3(a).
Test Performance. Each Test will be conducted consistent with Accepted Electrical Practices, Contract Conditions, Applicable Law, manufacturer recommendations, and the provisions of published test procedures developed by the Electric Power Research Institute (EPRI) Energy Storage Integration Council (ESIC) (or equivalent test procedures accepted as an Industry Standard for lithium ion battery energy storage systems) . At all times during a Test, the Project shall not be operated with abnormal operating conditions such as unstable load conditions. If conditions occur during a Test that are contrary to any of the foregoing, Buyer may postpone or reschedule all or part of such Test in its reasonable discretion, in which case such Test shall be deemed an Incomplete Test.
Test Performance. The test frame and its attachments prescribed in paragraphs 2.1., 2.2., 2.3.1.,2.3.3., 2.4., 2.6. and 2.7. shall be attached securely to a test sled which shall be decelerated from an initial velocity to standstill such that the sled and its attached frame is subjected to deceleration falling within the bounds of the corridor specified graphically in Appendix 1 to Annex 3. Annex 3 - Appendix 1 Annex 3 – Appendix 1 SLED DECELERATION CORRIDOR AS A FUNCTION OF TIME (Frontal impact) Annex 3 - Appendix 2 Annex 3 – Appendix 2 POSITION OF TYPE 1 AND TYPE 2 TEST BLOCKS IN RELATION TO THE TEST FRAME x inner surface of vehicle roof 10 kg x partitioning system seat back 18 kg 200 mm dim. Z/2 dim. Z 18 kg 18 kg 50 mm Annex 3 - Appendix 3 Annex 3 – Appendix 3 POSITION OF THE PLANE OF MAXIMUM PARTITIONING SYSTEM DEFLECTION Y 300 mm Plane of maximum partitioning system deflection Rearmost seat positioned according to Xxxxx 3, para. 2.7. Y Annex 4 Annex 4 EXAMPLE OF AN APPARATUS TO TEST THE STRENGTH OF PARTITIONING SYSTEMS A B D E C
Test Performance. 4.5.1 All test and procedures must comply and be approved/cleared by the FDA.
Test Performance. 15.1. HVG FABRICS PTY LTD does not guarantee the performance limits stated in any quotation, tender or Agreement unless such limits are expressly guaranteed by HVG FABRICS PTY LTD in writing.
